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Abstract
Because of combining the genetic information of multiple loci, multilocus association studies (MLAS) are expected to be
more powerful than single locus association studies (SLAS) in disease genes mapping. However, some researchers found
that MLAS had similar or reduced power relative to SLAS, which was partly attributed to the increased degrees of freedom
(dfs) in MLAS. Based on partial least-squares (PLS) analysis, we develop a MLAS approach, while avoiding large dfs in MLAS.
In this approach, genotypes are first decomposed into the PLS components that not only capture majority of the genetic
information of multiple loci, but also are relevant for target traits. The extracted PLS components are then regressed on
target traits to detect association under multilinear regression. Simulation study based on real data from the HapMap
project were used to assess the performance of our PLS-based MLAS as well as other popular multilinear regression-based
MLAS approaches under various scenarios, considering genetic effects and linkage disequilibrium structure of candidate
genetic regions. Using PLS-based MLAS approach, we conducted a genome-wide MLAS of lean body mass, and compared it
with our previous genome-wide SLAS of lean body mass. Simulations and real data analyses results support the improved
power of our PLS-based MLAS in disease genes mapping relative to other three MLAS approaches investigated in this study.
We aim to provide an effective and powerful MLAS approach, which may help to overcome the limitations of SLAS in
disease genes mapping.
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Introduction
Association studies are widely used to identify genetic variants
underlying complex human diseases, such as osteoporosis [1,2],
obesity [3] and diabetes [4]. Association studies can be generally
classified into two classes: single locus association studies (SLAS)
and multiple loci association studies (MLAS) [5]. SLAS detect
associations between each individual locus and target traits.
Because of being simple to implement, SLAS are popular in
current association mapping of disease genes. However, there are
several limitations for SLAS. First, the performance of SLAS
largely depends on the linkage disequilibrium (LD) between testing
loci and potential causal loci. SLAS may have low power if the LD
between testing loci and potential causal loci is weak. Second, it is
well known that the risks of complex human diseases are usually
determined by the main and interactive effects of multiple genetic
and environmental factors [6]. Because SLAS conduct association
tests at each individual locus, it is difficult to detect genetic
interactive effects using SLAS. Third, association studies usually
request a multiple testing adjustment procedure to ensure overall
appropriate type I error rates, such as Bonferroni correction [7,8]
and false discovery rates [9,10,11]. These multiple testing
adjustment procedures are sometimes too strict, and may miss
real disease-gene associations in large scale SLAS.
The limitations of SLAS promote the development of MLAS
approaches. Because MLAS can simultaneously consider the
genetic information of multiple loci, it is expected that MLAS were
more powerful than SLAS in disease genes mapping. Multilinear
regression is one of the major multivariate analyses approaches,
and has been applied to MLAS [12,13]. In multilinear regression,
target trait values can be modeled as a function of independent
variable vector corresponding to the genotypes of multiple loci in
candidate genetic regions. Because of large degrees of freedom
(dfs) in statistical tests, it is difficult to directly apply multilinear
regression to large genetic regions for MLAS. Previous studies
found that multilinear regression had similar or reduced power
relative to SLAS in disease gene mapping [14,15,16]. The
increased power gained from combining the genetic information
of multiple loci may be compromised by increasing dfs in
multilinear regression. Additionally, the genotypes of multiple
densely spaced loci are usually correlated due to LD, which may
induce collinearity of genotype vectors, and decrease the power of
multilinear regression for MLAS [12].
Several methods have been proposed to deal with large dfs in
multilinear regression. The first one is tagSNPs-based multilinear
regression [14,15]. A set of tagSNPs capturing majority of the
genetic information of candidate genetic regions, and having no or
weak collinearity among each other, can be selected and included
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decrease dfs in multilinear regression, it will result in the lost of genetic
information and therefore decrease the power of MLAS, especially in
the genetic regions with weak LD. Additionally, the power of tagSNPs-
based association studies is affected by the performance of tagSNPs
selection methods [17,18]. The second method applies dimension
reduction techniques, such as principle component analysis (PCA)
[12,19] and Fourier transformation [20], to genotype data and
produces a set of orthogonal predictors capturing majority of the
genetic information of candidate genetic regions. One can then detect
associations between the extracted orthogonal predictors and target
traits under multilinear regression [12,20]. Besides the multilinear
regression-based MLAS approaches mentioned above, other MLAS
approaches are also available, such as genetic similarity-based MLAS
[21,22] and Bayesian-based MLAS [23].
Recently, Taylor and Tibshirani proposed the tail strength
measure (TSM) for assessing the overall significance levels of
multiple hypotheses tests in microarray studies [24]. Using
simulated and real microarray datasets, Taylor and Tibshirani
illustrated the performance of TSM, and suggested that TSM
could be used to assess overall significance levels in microarray and
other genetic studies with a number of hypotheses tests [24]. TSM
may be able to evaluate overall association strength of multiple loci
in association studies. However, the performance of TSM for
MLAS remains unclear.
In this paper, we present a MLAS approach based on partial
least-squares (PLS) analysis, while avoiding large dfs. As an
extension of multiple linear regression, PLS generalizes and
combines the features of PCA and multilinear regression [25,26].
Through maximizing the covariance of denpendent and indenpen-
dent variables, PLS searches for the components capturing majority
of the information contained in indenpendent variables as well as in
the relations between denpendent and indenpendent variables. In
Materials and Methods section, we first formulate our PLS-based
MLAS. Using simulated data based on real data from the HapMap
project, we show that PLS-based MLAS are simple to implement,
and generally provides improved power in diseases genes mapping
relative to tagSNPs-based MLAS, PCA-based MLAS and TSM-
based MLAS. Finally, a real data is used to assess the performance
of PLS-based MLAS for genome-wide MLAS.
Results
Simulations
The type I error rates of the four MLAS approaches under
various scenarios investigated in this study are normal and not
shown to simplify our presentation. The power comparison results
of the four MLAS approaches under the epistatic model are
presented in Figure 1. As shown by the data, PLS-based MLAS
attained the highest power, followed by WTSM and PCA-based
MLAS across various parameter settings. TagSNPs-based MLAS
and FTSM appeared to perform less well than other MLAS
approaches in this study.
Figure 2 presents the power comparison results of the four
MLAS approaches under the additive model. In the simulation
study of genetic effect, PLS-based MLAS obtained higher power
than other MLAS approaches under various genetic effects except
for 0.01. WTSM and PCA-based MLAS showed similar power,
and outperformed tagSNPs-based MLAS and FTSM. In the
simulation study of D’, PLS-based MLAS appeared to significantly
perform better than other MLAS approaches investigated in this
study.
Genome-wide MLAS of Lean Body Mass
Figure 3 summarizes the genome-wide MLAS results of lean
body mass implemented by PLS-based MLAS. Beside TRHR
detected in previous genome-wide SLAS of lean body mass [27],
we identified 16 novel genes with significant association signals for
lean body mass. To evaluate the efficiency and robust of our PLS-
based MLAS, we further compared the MLAS and SLAS results
of the 17 genes detected in this study, as shown by Table 1.
Discussion
Large dfs is one of the major issues with MLAS. To deal with
this problem, we propose a PLS-based MLAS approach, while
avoiding large dfs. Simulation study based on real data from the
HapMap project suggests that our PLS-based MLAS generally
outperformed other three popular MLAS approaches under
various scenarios investigated in this study. PLS is suitable to
handle the data with many independent variables as well as
multicollinearity among the variables [28,29], which are common
in genotype data due to LD. It has been suggested that PLS might
provide more genetic information than PCA do, when interactive
effects [30] or multicollinearity [29] exist. In contrast, because
PCA only consider the characteristics of indenpendent variables,
the PCA components capturing major genetic information of
candidate genetic regions are not necessarily relevant for target
traits. Therefore, it is not surprising that PLS-based MLAS are
more powerful than PCA–based MLAS in this study.
PLS-based MLAS can easily be applied to genome-wide
association studies (GWAS). To investigate the performance of
Figure 1. Power comparing results of PLS-based MLAS (PLS_MLAS), PCA-based MLAS (PCA_MLAS), tagSNPs-based MLAS
(tagSNPs_MLAS), TSM-based MLAS using F test (FTSM) and TSM-based MLAS using Wald test (WTSM) under the epistatic model.
doi:10.1371/journal.pone.0016739.g001
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MLAS of lean body mass using a real sample consisting of 973
unrelated USA whites. To the best of our knowledge, this is the
first multilocus GWAS of lean body mass. Besides TRHR detected
in previous genome-wide SLAS of lean body mass [27], PLS-based
MLAS identified 16 novel genes that may be missed by previous
study. Although the 16 genes did not achieve genome-wide
significance level (1.32610
27) in previous genome-wide SLAS of
lean body mass, most of them still attained small p values (Table 1).
Biological studies of these genes may provide some evidences for
their roles in the genetic regulation of lean body mass. For
instance, it has been found that serum TNFSF10 (also named
TRAIL) concentration was significantly correlated with lean body
mass [31]. TNFSF10 might play an important role in skeletal
myoblast differentiation [32]. Rat experiments observed that
ADAMTS1 was highly expressed in skeletal muscle [33], and
muscular development appeared to rely on ADAMTS1 [34].
Replication studies are needed to validate the associations between
the 17 genes and lean body mass detected in this study.
To illustrate the performance of our approach, we developed
PLS-based MLAS for quantitative traits in this study. However,
PLS-based MLAS can easily be extended to qualitative traits
under logistic regression model. Covariates can also be incorpo-
rated into PLS-based MLAS due to the flexibility of regression
analyses. Additionally, because permutations are used to evaluate
the significance level of testing statistic, our PLS-based MLAS do
not depend on specific statistical assumption, for instance the
normality assumption of target traits. The computational cost of
PLS-based MLAS is also acceptable for real studies. For instance,
our genome-wide MLAS of lean body mass using PLS-based
MLAS needed about 21 days (running on Dell computer cluster
with four Intel Xeon 1.6 GHz processors and 4G memory).
An issue with PLS-based MLAS is how many PLS compoments
we should include into analyses. Some methods developed for
PCA can be used here. For instance, we can select top m of the
ordered PLS components that explain certain proportions of total
genotypic variance (for example, selecting top m PLS components
explaining 80% of total genotypic variance) [12]. It should be
noted that using too many components in PLS-based MLAS and
PCA-based MLAS may also decrease the power of MLAS due to
increasing dfs.
Taylor and Tibshirani originally proposed TSM to assess the
overall significance levels of multiple hypotheses tests in micro-
array studies [24]. Here, we applied TSM to MLAS, and
implemented a permutation procedure to estimate the empirical
p value of TSM statistic. Although TSM-based MLAS performed
less well than PLS-based MLAS, TSM is easy to calculate and may
provide a simple alternative for MLAS. Additionally, we found
that WTSM significantly outperformed FTSM in our simulation
study, which suggest the impact of statistical tests used for
calculating TSM on the performance of TSM-based MLAS.
Based on our simulation study results, we suggest that it was better
Figure 2. Power comparing results of PLS-based MLAS (PLS_MLAS), PCA-based MLAS (PCA_MLAS), tagSNPs-based MLAS
(tagSNPs_MLAS), TSM-based MLAS using F test (FTSM) and TSM-based MLAS using Wald test (WTSM) under the additive model.
doi:10.1371/journal.pone.0016739.g002
Figure 3. Plot of genome-wide MLAS results of lean body mass implemented by PLS-based MLAS. Significant genes are highlighted in
red.
doi:10.1371/journal.pone.0016739.g003
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test and likelihood ratio test.
In summary, we present a simple and flexible MLAS approach
with small dfs. Simulation study and real GWAS data analyses
results support the improved performance of our PLS-based
MLAS in disease genes mapping relative to other popular MLAS
approaches investigated in this study. We aim to provide an
effective and powerful MLAS approach, which may help to
overcome the limitations of SLAS in disease genes mapping.
Materials and Methods
Ethics Statement
All studies were approved by the Institutional Review Boards of
University of Missouri-Kansas City. Informed-consent documents
were written by all study participants.
Extended Tukey’s 1-df interaction model
Consider a sample of n unrelated subjects with k genotyped
SNPs. Let Yi denote the quantitative trait value for subject i
(i=1,…,n), and Xij denote the genotype of subject i at SNP j
(j=1,…,k). In this study, we coded Xij to be 0, 1 or 2, representing
the copy number of minor allele for subject i at SNP j. Other
genotype coding scenarios can also be used, such as Xij =0 or 1
for genetic dominant or recessive models, if desired. The extended
Tukey’s 1-df interaction model proposed by Chatterjee N et al.
[13] was implemented here to model the relationship between
individual trait value Yi and genotype Xij. In this model, the SNPs
with large marginal genetic effects are assumed to have large
interactive genetic effects. Total interactive effects of all SNPs are
measured by weighted sum of the product of marginal effects of
each pair of SNPs through an interaction parameter c in the
extended Tukey’s 1-df interaction model, defined by
Yi~az
X k
j~1
bjXijzc
X
1ƒjvuƒk
bjbuXijXiuzei ð1Þ
where a is intercept. bj denotes the regression coefficient for SNP j.
c measures total interactive effects of all SNPs within candidate
genetic regions. ei denotes the residual environmental effect for
subject i, and is assumed to follow a normal distributation with
mean 0 and variance s2
e. A global test of associations between
candidate genetic regions and target traits equates testing the null
hypothesis H0: b=0(b=b1,…, bk) under multilinear regression.
Although the interactive effects of multiple SNPs are modeled as
an interaction parameter c in the extended Tukey’s 1-df
interaction model [13], it is still difficult to apply this model to
large genetic regions with many SNPs. The parameters needed for
large genetic regions in the extended Tukey’s 1-df interaction
model will become too many to implement.
PLS-based MLAS
Instead of directly using genotypes as regressor, we propose to
regress the PLS components derived from genotypes on target
traits under multilinear regression model. A standard iterative
process implemented by the pls package of R was used to derive
PLS components from genotypes in this study [35,36]. Briefly, let
Yj denote the residual phenotype vector, and Xj denote the
residual genotype matrix for the jth PLS component. wj represents
the first left singular vector of crossproduct matrix Sj =X j
TYj .u j
denotes the scores of Xj along the jth PLS component. During
each iteration, the scores uj was first calculated by
uj~Xjwj ð2Þ
The loading aj of Yj and loading bj of Xj at the jth PLS
component were then defined by
aj~Yj
Tuj and bj~Xj
Tuj ð3Þ
Finally, the residual phenotype vector Yj+1 and genotype matrix
Xj+1 for j+1 PLS component were calculated by
Yjz1~Yj - ujaj
T and Xjz1~Xj - ujbj
T ð4Þ
Suppose top m of ordered PLS components were further
included into multilinear regression analysis. Let Pij (j=1,…,m)
denote the score of subject i at the jth PLS component. PLS-based
multilinear regression can be defined as
Yi~az
X m
j~1
bjPijzei, ð5Þ
Where a is intercept. bj denotes the regression coefficient for the
jth PLS component. ei denotes the residual environmental effect
for subject i, and is assumed to follow a zero mean normal
distributation with variance s2
e. We can detect associations
between target traits and candidate genetic regions under multi-
linear regression. For statistical tests, a permutation procedure is
Table 1. Comparison of MLAS and SLAS results of the 17
genes detected by PLS-based MLAS of lean body mass.
Genes PLS-based MLAS SLAS
P values FDR P values
a FDR
ADAMTS1 1.00610
25 0.045 3.31610
25 0.514
ANGPT2 2.00610
25 1.00610
25 4.76610
24 0.906
ATP8A2 1.30610
24 0.045 0.016 0.919
DKK2 3.00610
25 0.037 5.66610
23 0.910
FAM13A1 8.10610
24 0.022 5.64610
24 0.906
FGF10 1.00610
25 0.037 1.16610
24 0.753
GPR158 4.00610
25 1.00610
25 1.56610
24 0.798
PTPRM 3.00610
25 2.00610
25 6.40610
23 0.910
SDK2 7.00610
25 3.00610
25 0.029 0.935
SLC28A3 3.60610
24 5.00610
25 1.36610
23 0.909
TNFRSF21 0.020 6.68610
23 1.74610
24 0.811
TNFSF10 3.00610
25 0.039 0.020 0.919
TRHR 2.20610
23 0.021 7.55610
28 0.029
TRPC6 1.24610
23 0.013 2.97610
23 0.910
TSPYL5 1.90610
24 0.016 1.62610
23 0.910
ZBTB43 1.00610
25 0.018 3.53610
23 0.910
ZFP37 3.00610
25 0.028 0.011 0.910
adenote the smallest P value of each gene obtained from our previous genome-
wide SLAS of lean body mass.
doi:10.1371/journal.pone.0016739.t001
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statistic of PLS-based MLAS in each replicate. The significance
level of testing statistic of PLS-based MLAS can be evaluated
according to the obtained empirical distribution.
TSM-based MLAS
We also investigated the performance of TSM for MLAS.
Suppose k genotyped SNPs within a candidate genetic region.
Association tests can be conducted at each SNP, and p(1)#p(2)
#…#p(k) denote the ordered p values of the k SNPs. TSM can be
defined as
TSM~
1
k
X k
i~1
(1{p(i)
kz1
i
) ð6Þ
If none of SNPs within the candidate genetic region is associated
with target traits, p(i) should follow a beta distribution with
expected value i/(k+1), and TSM should have an expected value
0. Otherwise, p(i) will deviate from its expected value i/(k+1), and
result in a positive value of (1{p(i)
kz1
i ). Large positive TSM
value support the association between the candidate genetic region
and target traits [24].
Taylor and Tibshirani showed that TSM approached normal
distribution under large k (Equation 6), which could be used to
determine the significance level of TSM statistic [24]. However, in
a typical MLAS, the number of hypothesis test k (Equation 6)
within a candidate genetic region is usually not large enough to
approach normal distribution for TSM. In this study, we
implemented a permutation procedure to estimate the empirical
p value of TSM statistic.
Simulations
Simulation study was used to assess the performance of our
PLS-based MLAS as well as tagSNPs-based MLAS, PCA-based
MLAS and TSM-based MLAS. HAPGEN program was used for
genotype simulations [37,38]. Based on known haplotype data,
HAPGEN can simulate whole genome genotype data by
implementing a hidden Markov model. Specific for this study,
the phased haplotype data, minor allele frequencies (MAF) and D’
of chromosome 6 of Caucasian were downloaded from the
HapMap website (http://hapmap.ncbi.nlm.nih.gov/downloads/
index.html.en). There were total 262,658 SNPs at chromosome 6.
To simulate genes with various genetic structures, we randomly
selected 10,000 genetic regions from chromosome 6. Each region
contained 14 consecutive SNPs with 0.2#MAF#0.5 and pre-
assigned ranges of D’ between adjacent SNPs (Table 2). During
each replicate, one of the 10,000 genetic regions was first
randomly selected. HAPGEN was then used to simulate the
genotype data of the selected genetic region with default running
parameters recommended by HAPGEN developers [37,38].
Genetic epistatic and additive models were used for quantitative
phenotype simulations. Let Yi denote the trait value of subject i,
defined by
Yi~az
X k
j~1
bjXijz
X
1ƒjvuƒk
cjuXijuzei ð7Þ
where a is intercept. bj denotes the additive effect of SNP j. Xij (Xij
=0,1 or 2) denotes the copy number of high risk allele for subject i
at SNP j. Without loss of generality, we supposed that there was an
interactive effect between the high risk alleles of SNP j and SNP u
under the epistatic model.cju denotes the interactive effect between
SNP j and SNP u, and equate 0 in the additive model. For the
epistatic model, Xiju was assigned 1 if the genotype vector of SNP j
and SNP u was either of (2,2), (2,1) or (1,2), and 0 otherwise. ei
denotes the residual environmental effect of subject i, and follow a
zero-meannormaldistributionwithvariances2
e.Underthe epistatic
model, SNP 6 and SNP 10 of the 14 SNPs were simulated as causal
loci with additive effects and an interactive effect between SNP 6
and SNP 10. Under the additive model, SNP 8 of the 14 SNPs
within selected genetic region was simulated as causal locus with
additive geneticeffect.Phenotypic variancesandD’ofthesimulated
genes were controlled to simulate various scenarios of association
studies. Detailed parameter designs are presented in Table 2.
The simulated genotype (excluding causal SNP 6 and SNP 10 in
the epistatic model and causal SNP 8 in the additive model) and
phenotype data were simultaneously analyzed by tagSNPs-based
MLAS, PLS-based MLAS, PCA-based MLAS and TSM-based
MLAS. The F test was used here to compare the performance of
various MLAS approaches. For tagSNPs-based MLAS, 3 of 12
SNPs (in the epistatic model) or 13 SNPs (in the additive model)
were first selected as tagSNPs using hmmlsselect program [39].
The selected 3 tagSNPs were then included into the extended
Tukey’s 1-df interaction model (Equation 1) for MLAS using F
test. For PLS-based MLAS and PCA-based MLAS, the first PLS
and PCA components with the largest genotype variance in PLS
and PCA analyses were included into multilinear regression
analyses for MLAS in this study. For TSM-based MLAS, F test
was first conducted at each SNP to obtain SLAS P values. The
TSM statistic based on F test (FTSM) was then calculated for each
gene (Equation 6). Additionally, the TSM statistic based on Wald
test (WTSM) (implemented by PLINK [40]) was also calculated,
and compared with FTSM to investigate potential impact of
statistical tests on the performance of TSM-based MLAS. 2,000
permutations were conducted in each replicate to estimate the
empirical p values of testing statistics of PLS-based MLAS, PCA-
based MLAS and TSM-based MLAS.
Table 2. Parameter configurations used in our simulation
study.
Genetic effect
a
Epistatic model D’ SNP6 SNP10 SNP66SNP10
0.9,1.0 0.020 0.010 0.000
0.8,0.9 0.018 0.008 0.004
0.7,0.8 0.016 0.006 0.008
0.6,0.7 0.014 0.004 0.012
Genetic effect
b
Additive model D’ SNP8
0.9,1.0 0.01
0.8,0.9 0.02
0.7,0.8 0.03
0.6,0.7 0.04
adenote the phenotypic variance explained by additive effects of causal SNP 6
and SNP 10 as well as interactive effect between SNP 6 and SNP 10,
respectively.
bdenote the phenotypic variance explained by additive effect of causal SNP 8.
cthe basic parameter configuration is highlighted in bold. Each possible
parameter setting can be obtained by replacing one entry of the basic
parameter configuration with a different entry of corresponding parameter.
doi:10.1371/journal.pone.0016739.t002
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each replicate, 800 individuals were simulated. Power and type I
error rates were calculated respectively as the proportions of
positive association results (P values # 0.05) obtained from the
simulated genes with and without genetic effects in 5,000
replicates. All our data simulations and analyses were implement-
ed with statistical package R [35] except for WTSM (implemented
by PLINK [40]).
Application to Lean Body Mass GWAS Data
To investigate the efficiency of PLS-based MLAS, we applied it
to a real GWAS data consisting of 1,000 unrelated US whites. The
characteristics of this sample have been detailed in previous single
locus GWAS of lean body mass [27]. Affymetrix 500 k SNP arrays
were used to genotype a total of 500,568 SNPs. After quality
control, 973 subjects and 379,319 SNPs relating to 12,828 genes
were retained for our genome-wide MLAS of lean body mass.
PLS-based MLAS approach was used to detect associations
between each gene and lean body mass. 100,000 permutations
were conducted to evaluate the empirical p value of each gene. To
correct for multiple testing, false discovery rate (FDR) q value was
also calculated from 100,000 permutations [41,42]. Briefly, let
Sobserve denote the observed PLS statistic vector with element
Si
observe (i=1,2,3…,12,828) in the lean body mass data. Snull
denotes the PLS statistic matrix with element S
ij
null
(i=1,2,3…,12,828 and j=1,2,3…,100,000), derived from
100,000 permutations. The FDR q value of gene m (denoted as
qm, m=1,2,3…,12,828) was calculated by
qm~
fnull
fobserve
ð8Þ
where fnull denotes the proportion of Snull with S
ij
null$Sm
observe, and
fobserve denotes the proportion of Sobserve with Si
observe$Sm
observe
[41,42]. Significant associations were defined by FDR q
values#0.05. Additionally, the FDR q value of each gene in
previous single locus GWAS of lean body mass was also calculated
with the qvalue package of R [35,43,44].
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